title: Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts.
abstract: Phagocytic clearance of apoptotic cells by macrophages is an essential part in the resolution of inflammation. It coincides with activation of repair mechanisms, including accumulation of extracellular matrix. A possible link between clearance of apoptotic debris and accumulation of extracellular matrix has not been investigated. Production of collagen was measured in primary fibroblasts cocultured with macrophages. Ingestion of apoptotic cells by monocyte-derived macrophages led to up-regulation of collagen. Direct contact between macrophages and fibroblasts was not required for collagen up-regulation. Macrophages produced TGF-beta following ingestion of apoptotic cells, but the levels of this cytokine were lower than those required for a significant up-regulation of collagen. Simultaneously, the levels of TGF-beta-induced (TGFBI), or keratoepithelin/BIGH3, mRNA and protein were increased. In contrast, primary alveolar macrophages stimulated collagen production without exposure to apoptotic cells; there was no further increase in the levels of TGFBI, mRNA or protein, or collagen after ingestion of apoptotic cells. Stimulation of fibroblasts with TGFBI down-regulated MMP14 levels, decreased DNA binding by p53, increased DNA binding by PU.1, and up-regulated collagen protein but not mRNA levels. Overexpression of MMP14 or p53, or small interfering RNA-mediated inhibition of PU.1 led to an increase in MMP14 and a decline in collagen levels, whereas small interfering RNA-mediated inhibition of MMP14 led to elevation of collagen levels. In conclusion, monocyte-derived but not alveolar macrophages produce TGFBI following ingestion of apoptotic cells, leading to the down-regulation of MMP14 levels in fibroblasts through a mechanism involving p53 and PU.1, and to subsequent accumulation of collagen.
authors: University of Maryland School of Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, MD 21201, USA.
authors: Natalia
authors: N
authors: Nacu
authors: Irina G
authors: IG
authors: Luzina
authors: Kendrick
authors: K
authors: Highsmith
authors: Virginia
authors: V
authors: Lockatell
authors: Kerill
authors: K
authors: Pochetuhen
authors: Zachary A
authors: ZA
authors: Cooper
authors: Michael P
authors: MP
authors: Gillmeister
authors: Nevins W
authors: NW
authors: Todd
authors: Sergei P
authors: SP
authors: Atamas
mesh_terms: D017209:Apoptosis; D002478:Cells, Cultured; D018920:Coculture Techniques; D003094:Collagen / Q000378:metabolism*; D004247:DNA / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000096:biosynthesis*; D005347:Fibroblasts; D006801:Humans; D008264:Macrophages / Q000166:cytology* / Q000378:metabolism*; D053511:Matrix Metalloproteinase 14 / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D015534:Trans-Activators / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000096:biosynthesis*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D015854:Up-Regulation; D000099232:Proto-Oncogene Protein Spi-1; D000099222:betaIG-H3 Protein
chemical_list: D003094:Collagen; D004247:DNA; D016326:Extracellular Matrix Proteins; D053511:Matrix Metalloproteinase 14; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D016212:Transforming Growth Factor beta; D016159:Tumor Suppressor Protein p53; D000099232:Proto-Oncogene Protein Spi-1; D000099222:betaIG-H3 Protein; C507086:MMP14 protein, human